U.S., Feb. 1 -- ClinicalTrials.gov registry received information related to the study (NCT06802874) titled 'Maternal-fetal Outcomes of Genital Blood Loss Beyond 18 Weeks of Pregnancy' on Dec. 30, 2024.
Brief Summary: The primary objective is to assess in terms of frequency the adverse outcomes (premature birth, maternal-fetal haemorrhage, maternal fetal-neonatal death) of pregnancies of women attending the obstetric-gynaecological emergency department for genital bleeding beyond the 18th week of pregnancy.
Study Start Date: Nov. 15, 2023
Study Type: OBSERVATIONAL
Condition:
Blood Loss
Recruitment Status: RECRUITING
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
Disclaimer: Curated by HT Syndication....